Cuprina Holdings (Cayman) (NASDAQ:CUPR) Trading 49.3% Higher – Here’s Why

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR)’s stock price traded up 49.3% during trading on Thursday . The company traded as high as $3.70 and last traded at $3.30. 3,155,123 shares traded hands during mid-day trading, an increase of 2,429% from the average session volume of 124,752 shares. The stock had previously closed at $2.21.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a research report on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Cuprina Holdings (Cayman) has an average rating of “Sell”.

Cuprina Holdings (Cayman) Trading Down 27.7%

The company has a 50-day simple moving average of $2.53. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.35 and a quick ratio of 2.35.

Cuprina Holdings (Cayman) (NASDAQ:CUPR) last issued its quarterly earnings results on Monday, April 27th. The company reported ($0.40) earnings per share (EPS) for the quarter. The firm had revenue of $0.01 million during the quarter.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.